Hear insights from #ACCPresident@ChrisKramerMD on the groundbreaking CRISPR-Cas9 trial presented at #AHA25 and what it means for cardiovascular care.
Get full details ➡️ https://t.co/z0hbFx8BLU #CardioX#ACCAnywhere
✨️Thrilled to see @UVA MS2 Ceylan Metin present our work from the @iPRIMEuva Coronary Atherosclerosis in Virginia (#CAVA) cohort at #AHA25, showing that modest ⏫️ in 🩸#A1C levels, even below prediabetic thresholds predict high risk plaque on 🫀#yesCCT@ToddVillinesMD
At #AHA25 we reported baseline SMILE data linking epicardial fat biochemistry to microvascular perfusion in women with ANOCA.
Higher saturated fatty acids and lower EAT T1 were associated with reduced perfusion — imaging the metabolic–vascular axis in vivo @CardioUva@UVACardsFellows #whyCMR
✨️Lack of ♀️ representation compromises nation-wide generalizability of data, costs billions in healthcare 💰💰, and hinders innovation.
✨️Innovate to reduce participation burden with 'teleresearch'
💪Powerful close to the #CVDinWomen symposium at #UVA. The renowned @pamelasdouglas, @noshreza and Dr. Tracy Wang deliver inspiring remarks on closing the ♀️gender gap in #CV trials
✨️ We need more women investigators to recruit more women participants! 🧵
@PRodriguezMD and @ChangeAtHeart highlight the
1️⃣ Importance of #PrecisionMedicine endotyping of NOCAs to guide targeted therapies
2️⃣ Critical role of coronary functional testing in understanding #Ischemia beyond obstructive disease
👭🫀 Engaging session on Unraveling the mystery of (A/I/MI) NOCAs at the #UVA#CVDinWomen symposium.
🌟Dr. Jonathan Lindner leads a masterclass in microvascular physiology, and🧵
Managing #CVHealth in pregnancy at the CVD in Women Symposium at #UVA: @GarimaVSharmaMD, @AkoczoAgnes, and Dr. Chris Ennen highlight the role of
🤰comprehensive maternal risk stratification
🤝🩺multidisciplinary teams
📊 APOs driving premature #CVD risk.
🎯 Personalized sex and Gender specific strategies
📊 Sex specific differences in plaque progression
💊 Lipid management across a woman’s lifespan
🌍 The impact of social determinants & risk on prevention
#WomensHeartHealth#CVPrevention#Cardiology
✨️Insightful session on #CVPrevention at the #CVD in Women Symposium at #UVA with compelling talks from Dr. Gina Lundberg, @AmitRPatelMD, and Dr. Aretha Sutter highlighting the importance of 🧵
🔑✨️Powerful keynote session at the CVD in Women Symposium @UVA featuring heartfelt patient testimonials from strong, inspiring women — reminding us of our WHY in advancing #womenshearthealth. 💖 Their stories drive our mission forward every day. @PRodriguezMD@ChrisKramerMD
Stress MR III | DC 2025 🎯
3 yrs🎂. Classic theory, cross-disciplinary collaboration, new discoveries, and inspiring discussions, practical hands-on sessions leaded from 12 experts! Old friends, new faces.
Congrats Amit & Ibrahim 🎉👏
🎉 Successful inaugural cases today for the UVA Coronary Function Testing (CFT) Program — led by Dr. Patrick Stafford!
Grateful for our incredible multidisciplinary team. A major milestone for the UVA Women’s Heart Care Program.
🌸 Our Microvascular Section is growing. It’s time to define endotypes and tailor therapy in women and men.
#WIC #CMD #ChestPain #CFT #yesCCT #whyPET #whyCMR #imaging #TeamUVA @UVACardsFellows@CardioUva@UvaDOM@uvahealthnews
Great energy at the @FiRSTSCCT commitee meeting—so inspiring to see the passion and commitment to advancing the field and supporting early-career imagers! #SCCT2025#yesCCT@Heart_SCCT
So proud of my team for presenting our work on contrast-enhanced CT in aortic stenosis: Assessment of Fibrocalcific Remodeling and Correlation with Echocardiographic Parameters. Exciting science and even better teamwork! 👏🫀 #SCCT2025#yesCCT@Heart_SCCT@UVA@CardioUva@UVACardsFellows
Incredible vision from @Heart_SCCT and leaders like Dr. Leslie Shaw. Prevention is the future. Powerful reminder: ‘ACS is treatment failure.’ Time to shift the paradigm. #SCCT2025#CVPrevention